Mohammed Alshahrani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammed Alshahrani has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Nassar
Department of Dermatology and Venereology, Tanta University, Egypt
2 shared publications- Abdulaziz Abdullah Almohanna
College of Medicine , Imam Mohammad Ibn Saud Islamic University (IMSIU) , Riyadh , Saudi Arabia , imamu.edu.sa
1 shared publication Abdullah Abualiat
The Armed Forces Hospitals‐Southern Region (AFHSR) Khamis Mushayt Aseer Province Saudi Arabia
1 shared publicationAbdullah Aljubran
The Armed Forces Hospitals‐Southern Region (AFHSR) Khamis Mushayt Aseer Province Saudi Arabia
1 shared publication- Adel Alfaifi
Department of Dermatology, The Armed Forces Hospitals-Southern Region, Khamis Mushayt, Aseer Province, Saudi Arabia
1 shared publication - Afnan Madkhali
Jazan University Hospital, Jazan, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 15 May 2025
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 18 (1)
Glomus tumor of the scrotum: an intraoperative differential diagnostic tip
Glomus tumors are rare, benign neoplasms arising from glomus bodies, primarily located in the subungual region and upper extremities, but uncommonly reported in areas such as the scrotum. Here, we describe a unique case of a glomus tumor of the scrotal skin in a 28-year-old male presenting with a two-year history of a painful, gradually enlarging scrotal nodule. Clinical examination revealed a tender oblong nodule, and dermoscopy suggested a benign neoplasm. Imaging and initial biopsy confirmed the lesion as a possible glomus tumor. Remarkably, during biopsy, the tumor spontaneously and completely “popped out”, narrowing the differential diagnosis to glomus tumor, angiolipoma, and epidermoid cyst. Histopathology confirmed the diagnosis of a glomus tumor, showing classic features including thick-walled blood vessels surrounded by smooth muscle actin-positive cells and a pseudocapsule. Postoperative pain resolution supported the clinical diagnosis. This case highlights the importance of considering glomus tumors in the differential diagnosis of painful scrotal lesions, especially when a mass exhibits spontaneous ejection during manipulation. To our knowledge, this is the first reported case of a scrotal glomus tumor in Saudi Arabia.
- 15 May 2025
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 18 (1)
Open AccessGlomus tumor of the scrotum: an intraoperative differential diagnostic tip
Glomus tumors are rare, benign neoplasms arising from glomus bodies, primarily located in the subungual region and upper extremities, but uncommonly reported in areas such as the scrotum. Here, we describe a unique case of a glomus tumor of the scrotal skin in a 28-year-old male presenting with a two-year history of a painful, gradually enlarging scrotal nodule. Clinical examination revealed a tender oblong nodule, and dermoscopy suggested a benign neoplasm. Imaging and initial biopsy confirmed the lesion as a possible glomus tumor. Remarkably, during biopsy, the tumor spontaneously and completely “popped out”, narrowing the differential diagnosis to glomus tumor, angiolipoma, and epidermoid cyst. Histopathology confirmed the diagnosis of a glomus tumor, showing classic features including thick-walled blood vessels surrounded by smooth muscle actin-positive cells and a pseudocapsule. Postoperative pain resolution supported the clinical diagnosis. This case highlights the importance of considering glomus tumors in the differential diagnosis of painful scrotal lesions, especially when a mass exhibits spontaneous ejection during manipulation. To our knowledge, this is the first reported case of a scrotal glomus tumor in Saudi Arabia.
- Open Access
- 6 June 2024
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 35 (1) , 2361106
Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials
Purpose: This study aimed to evaluate the efficacy of tranexamic acid (TXA) in treating melasma through a meta-analysis and systematic review of randomized controlled trials (RCTs). The study focused on identifying associated adverse effects and comparing TXA's effectiveness with other melasma treatments.Materials and methods: Following PROSPERO and PRISMA guidelines, an extensive electronic search was conducted across four databases for RCTs on TXA use in melasma. Inclusion criteria encompassed full-text English articles with specific outcome measures, while studies with high bias risk or non-English publications were excluded. Data were extracted from 22 relevant studies and analyzed using the RevMan software, with heterogeneity identified using I² statistics and forest plots.Results: A total of 22 studies with 1280 patients were included. TXA was administered orally, topically, or via injection, with treatment durations ranging from 8 weeks to nearly 2 years. TXA significantly reduced melasma severity, evidenced by reductions in MASI, mMASI, MI, and hemi-MASI scores. Oral TXA showed the most substantial decrease in MASI scores, followed by injections and topical applications. However, studies exhibited high heterogeneity, particularly in combined treatments. Adverse effects included gastrointestinal discomfort, skin irritation, and menstrual irregularities.Conclusions: TXA is effective in treating melasma, either alone or combined with other treatments. Despite significant reductions in melasma severity, further research is necessary to standardize TXA administration methods and address long-term effects. The high heterogeneity observed suggests a need for more consistent treatment protocols.
- 6 June 2024
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 35 (1) , 2361106
Open AccessTranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials
Purpose: This study aimed to evaluate the efficacy of tranexamic acid (TXA) in treating melasma through a meta-analysis and systematic review of randomized controlled trials (RCTs). The study focused on identifying associated adverse effects and comparing TXA's effectiveness with other melasma treatments.Materials and methods: Following PROSPERO and PRISMA guidelines, an extensive electronic search was conducted across four databases for RCTs on TXA use in melasma. Inclusion criteria encompassed full-text English articles with specific outcome measures, while studies with high bias risk or non-English publications were excluded. Data were extracted from 22 relevant studies and analyzed using the RevMan software, with heterogeneity identified using I² statistics and forest plots.Results: A total of 22 studies with 1280 patients were included. TXA was administered orally, topically, or via injection, with treatment durations ranging from 8 weeks to nearly 2 years. TXA significantly reduced melasma severity, evidenced by reductions in MASI, mMASI, MI, and hemi-MASI scores. Oral TXA showed the most substantial decrease in MASI scores, followed by injections and topical applications. However, studies exhibited high heterogeneity, particularly in combined treatments. Adverse effects included gastrointestinal discomfort, skin irritation, and menstrual irregularities.Conclusions: TXA is effective in treating melasma, either alone or combined with other treatments. Despite significant reductions in melasma severity, further research is necessary to standardize TXA administration methods and address long-term effects. The high heterogeneity observed suggests a need for more consistent treatment protocols.
- 8 March 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (7) , 840-843
A dermoscopic study of cutaneous myiasis: other findings
Background: Myiasis is a cutaneous infestation by the larvae of dipterous flies. It can be furuncular/nodular, papular, or pustular. Diagnosis of cutaneous myiasis depends mainly on clinical examination especially for the nodular form. The latter two forms can present diagnostic difficulties. Dermoscopy has been reported to be helpful. This report illustrates some of the dermoscopic features of this condition.Methods: The history, clinical findings, and dermoscopic findings of 15 affected individuals were documented.Results: Dermoscopy in all patients showed the posterior end of larvae (creamy‐white bodies and respiratory spiracles resembling birds’ legs with digitated feet). Larval motility and bubbles were noticed in 15 and 10 of patients, respectively. Skin surrounding the larvae showed hypopigmentation in 11 patients and an increase in dilated capillaries in 13.Conclusions: Dermoscopy can facilitate the diagnosis of myiasis particularly of the papular and pustular forms.
- 8 March 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (7) , 840-843
A dermoscopic study of cutaneous myiasis: other findings
Background: Myiasis is a cutaneous infestation by the larvae of dipterous flies. It can be furuncular/nodular, papular, or pustular. Diagnosis of cutaneous myiasis depends mainly on clinical examination especially for the nodular form. The latter two forms can present diagnostic difficulties. Dermoscopy has been reported to be helpful. This report illustrates some of the dermoscopic features of this condition.Methods: The history, clinical findings, and dermoscopic findings of 15 affected individuals were documented.Results: Dermoscopy in all patients showed the posterior end of larvae (creamy‐white bodies and respiratory spiracles resembling birds’ legs with digitated feet). Larval motility and bubbles were noticed in 15 and 10 of patients, respectively. Skin surrounding the larvae showed hypopigmentation in 11 patients and an increase in dilated capillaries in 13.Conclusions: Dermoscopy can facilitate the diagnosis of myiasis particularly of the papular and pustular forms.